China Money Network
Login
Join

OrbiMed Co-leads $20M Series A Round In Zentera Therapeutics

  • May 22, 2020 — 18:44 CST

This Data Is Locked!

This area is available only to Subscribers.

Zentera Therapeutics, a Shanghai-based biopharmaceutical company, has completed a US$20 million Series A round financing led by Tybourne Capital Management and OrbiMed Asia. Zentalis, through... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: